AstraZeneca AB and AstraZeneca plc v European Commission (C-457/10 P)

Judgment of 6 Dec 2012

law://eu/cjeu/2010/c-457-10/para_116@2026-11-14

116The General Court pointed out that the Court of Justice, in its judgment in Case C-223/01 AstraZeneca [2003] ECR I-11809, paragraphs 49 to 54, nevertheless considered that the interest of safeguarding public health required, in order for an application for MA of a generic medicinal product to be dealt with by way of the abridged procedure provided for in that provision, that the reference MA still be in force in the Member State concerned at the date when that application is lodged, and therefore precluded the use of that abridged procedure after the withdrawal of the reference MA.

AstraZeneca AB and AstraZeneca plc v European Commission (C-457/10 P)

Key facts

History · 1 version

Connections